These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 25641798

  • 21. Synthesis and biological evaluation of spongistatin/altohyrtin analogues: E-ring dehydration and C46 side-chain truncation.
    Paterson I, Aceña JL, Bach J, Chen DY, Coster MJ.
    Chem Commun (Camb); 2003 Feb 21; (4):462-3. PubMed ID: 12638950
    [Abstract] [Full Text] [Related]

  • 22. Actin-binding marine macrolides: total synthesis and biological importance.
    Yeung KS, Paterson I.
    Angew Chem Int Ed Engl; 2002 Dec 16; 41(24):4632-53. PubMed ID: 12481316
    [Abstract] [Full Text] [Related]

  • 23. Smenamide A Analogues. Synthesis and Biological Activity on Multiple Myeloma Cells.
    Caso A, Laurenzana I, Lamorte D, Trino S, Esposito G, Piccialli V, Costantino V.
    Mar Drugs; 2018 Jun 13; 16(6):. PubMed ID: 29899231
    [Abstract] [Full Text] [Related]

  • 24. Two new ring-contracted congeners of rhizopodin illustrate significance of the ring moiety of macrolide toxins on the actin disassembly-mediated cytotoxicity.
    Oku N, Matsumoto A, Matsunaga T, Asano Y, Kasai H, Matoba S, Igarashi Y.
    Chem Pharm Bull (Tokyo); 2014 Jun 13; 62(3):294-300. PubMed ID: 24583785
    [Abstract] [Full Text] [Related]

  • 25. Development of photoaffinity derivatives of the antitumor macrolide aplyronine A, a PPI-inducer between actin and tubulin.
    Kita M, Yamagishi K, Tsuchiya K, Seguchi Y, Nakane H, Kigoshi H.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6322-6331. PubMed ID: 29042221
    [Abstract] [Full Text] [Related]

  • 26. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y, Lu X, Chen K, Yan R, Li QS, Zhu HL.
    Bioorg Med Chem; 2012 Jan 15; 20(2):903-9. PubMed ID: 22192936
    [Abstract] [Full Text] [Related]

  • 27. Chivosazoles A and F, cytostatic macrolides from myxobacteria, interfere with actin.
    Diestel R, Irschik H, Jansen R, Khalil MW, Reichenbach H, Sasse F.
    Chembiochem; 2009 Dec 14; 10(18):2900-3. PubMed ID: 19852013
    [Abstract] [Full Text] [Related]

  • 28. The structural determinants of macrolide-actin binding: in silico insights.
    Melville JL, Moal IH, Baker-Glenn C, Shaw PE, Pattenden G, Hirst JD.
    Biophys J; 2007 Jun 01; 92(11):3862-7. PubMed ID: 17351011
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of microtubule assembly by a complex of actin and antitumor macrolide aplyronine A.
    Kita M, Hirayama Y, Yoneda K, Yamagishi K, Chinen T, Usui T, Sumiya E, Uesugi M, Kigoshi H.
    J Am Chem Soc; 2013 Dec 04; 135(48):18089-95. PubMed ID: 24228690
    [Abstract] [Full Text] [Related]

  • 30. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton.
    Spector I, Braet F, Shochet NR, Bubb MR.
    Microsc Res Tech; 1999 Oct 01; 47(1):18-37. PubMed ID: 10506759
    [Abstract] [Full Text] [Related]

  • 31. Synthesis of derivatives of potent antitumor bistramides D and A leading to the first crystal structure of natural bistramide D.
    Bauder C, Biard JF, Solladié G.
    Org Biomol Chem; 2006 May 21; 4(10):1860-2. PubMed ID: 16688329
    [Abstract] [Full Text] [Related]

  • 32. Truncated Actin-Targeting Macrolide Derivative Blocks Cancer Cell Motility and Invasion of Extracellular Matrix.
    Pipaliya BV, Trofimova DN, Grange RL, Aeluri M, Deng X, Shah K, Craig AW, Allingham JS, Evans PA.
    J Am Chem Soc; 2021 May 12; 143(18):6847-6854. PubMed ID: 33938740
    [Abstract] [Full Text] [Related]

  • 33. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM, Abdel-Aziz M, Canzoneri JC, Gary BD, Piazza GA.
    Arch Pharm (Weinheim); 2014 Sep 12; 347(9):650-7. PubMed ID: 24985336
    [Abstract] [Full Text] [Related]

  • 34. Bistramides A, B, C, D, and K: a new class of bioactive cyclic polyethers from Lissoclinum bistratum.
    Biard JF, Roussakis C, Kornprobst JM, Gouiffes-Barbin D, Verbist JF, Cotelle P, Foster MP, Ireland CM, Debitus C.
    J Nat Prod; 1994 Oct 12; 57(10):1336-45. PubMed ID: 7807120
    [Abstract] [Full Text] [Related]

  • 35. Trisoxazole macrolide toxins mimic the binding of actin-capping proteins to actin.
    Klenchin VA, Allingham JS, King R, Tanaka J, Marriott G, Rayment I.
    Nat Struct Biol; 2003 Dec 12; 10(12):1058-63. PubMed ID: 14578936
    [Abstract] [Full Text] [Related]

  • 36. Molecular docking and QSAR of aplyronine A and analogues: potent inhibitors of actin.
    Hussain A, Melville JL, Hirst JD.
    J Comput Aided Mol Des; 2010 Jan 12; 24(1):1-15. PubMed ID: 19890607
    [Abstract] [Full Text] [Related]

  • 37. Isolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolides.
    Hopkins CD, Wipf P.
    Nat Prod Rep; 2009 May 12; 26(5):585-601. PubMed ID: 19387496
    [Abstract] [Full Text] [Related]

  • 38. Total synthesis and biological evaluation of (-)-exiguolide analogues: importance of the macrocyclic backbone.
    Fuwa H, Mizunuma K, Sasaki M, Suzuki T, Kubo H.
    Org Biomol Chem; 2013 Jun 07; 11(21):3442-50. PubMed ID: 23538720
    [Abstract] [Full Text] [Related]

  • 39. Isolation, structure elucidation, and biological activity of maltepolides: remarkable macrolides from Myxobacteria.
    Irschik H, Washausen P, Sasse F, Fohrer J, Huch V, Müller R, Prusov EV.
    Angew Chem Int Ed Engl; 2013 May 10; 52(20):5402-5. PubMed ID: 23592574
    [No Abstract] [Full Text] [Related]

  • 40. Synthetic mimetics of actin-binding macrolides: rational design of actin-targeted drugs.
    Perrins RD, Cecere G, Paterson I, Marriott G.
    Chem Biol; 2008 Mar 10; 15(3):287-94. PubMed ID: 18355728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.